Home » Mercurius Health: driving innovative oncology solutions at ESTRO 2025
 Mercurius Health: driving innovative oncology solutions at ESTRO 2025

Mercurius Health: driving innovative oncology solutions at ESTRO 2025

Innovation and collaboration in cancer care are ever-evolving and an essential part of improving patient outcomes. ESTRO, the European Society for Radiotherapy and Oncology, plays a key role in advancing radiation oncology by bringing together specialists and industry leaders across the region to exchange knowledge and drive progress. This year’s congress will take place from 2 to 6 May in Vienna, Austria, providing a platform to explore the latest breakthroughs to strengthen multidisciplinary cancer care.

Mercurius Health Group, one of Europe’s leading providers of advanced oncology solutions, is preparing to participate in this prestigious event once again. Specialising in radiotherapy and nuclear medicine, Mercurius Health Group develops, operates, and supports over 15 oncology centres, with a presence in Germany, Spain, Portugal, and the UK, while also delivering services across Europe. With nearly 30 years of experience, the company is dedicated to strategic partnerships that enhance hospital capabilities and ensure cutting-edge treatments for oncology patients.

Mercurius Health Group takes a 360º approach to supporting oncology centres by providing integrated, turnkey solutions that cover every aspect of radiotherapy and nuclear medicine project development. From defining the clinical vision, design phase and equipment selection to procurement, project implementation, operations, and financing, our turnkey projects offer a seamless solution for hospitals seeking to enhance their oncology services. Its expertise spans a wide range of radiotherapy and nuclear medicine equipment and practices, as well as the construction and management of oncology facilities.

By managing the complete process, Mercurius Health Group ensures that hospitals and cancer centres receive not only the best technology fit but also comprehensive support in regulatory compliance, safety protocols, and clinical excellence. This approach allows healthcare providers to focus on delivering high-quality care while relying on Mercurius Health for the technical, clinical, and management aspects of their oncology departments.

Beyond all this, Mercurius Health Group operates its own centres, such as the WEGE Klinik (formerly Robert Janker Klinik), a renowned dedicated oncology hospital in Bonn, Germany, and CADPET, a nuclear medicine network in Spain. These facilities serve as active hubs for innovation, allowing the company’s clinical, technical, and management teams to remain at the forefront of advancements in cancer treatment. By directly engaging with real-world challenges, Mercurius Health Group continually refines its solutions and ensures that its partner institutions benefit from the most up-to-date oncology practices.

ESTRO’s vision for 2025, Transformative Innovation Through Partnership, highlights the importance of collaboration in advancing radiation oncology and multidisciplinary cancer care. This mission aligns closely with Mercurius Health’s dedication to fostering partnerships that drive innovation and improve clinical outcomes. By actively participating in ESTRO 2025, Mercurius Health Group aims to contribute its expertise to industry discussions, engage with fellow professionals, and showcase how its all-in-one approach is shaping the future of oncology services.

The congress will feature a dynamic programme of breakthrough research, panel discussions, pitch sessions, and interactive debates that connect the global radiation oncology community. Joint sessions with partner organisations will further extend the congress’s reach, fostering new collaborations and expanding its impact on the industry.As the healthcare landscape continues to evolve, Mercurius Health Group remains committed to bridging the gap in cancer treatment through continuous innovation and collaboration, including offering funding solutions, a common issue for many centres. Attendees at ESTRO 2025 are encouraged to connect with Mercurius Health’s team to learn more about its turnkey oncology solutions and holistic approach to supporting hospitals and cancer centres.

For more information about ESTRO 2025, visit the official website

For booking an appointment with one of Mercurius Health experts, click on this BOOKING link.

Leave a Reply

Your email address will not be published. Required fields are marked *

© 2021 Mercurius Health